famotidine has been researched along with Mastocytosis, Systemic in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolck, UW | 1 |
| Alfter, K | 1 |
| Homann, J | 1 |
| von Kügelgen, I | 1 |
| Molderings, GJ | 1 |
1 other study available for famotidine and Mastocytosis, Systemic
| Article | Year |
|---|---|
Cardiac mast cells: implications for heart failure.
Topics: Chronic Disease; Famotidine; Female; Heart Failure; Humans; Male; Mast Cells; Mastocytosis, Systemic | 2007 |